Lipella Pharmaceuticals Inc. Common Stock

LIPO US53630L1008

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Kaufman Jonathan H O	0.76 USD	10,000 Bought	7,590 USD	14/05/2024	14/05/2024
Kaufman Jonathan H O	0.87 USD	25,000 Bought	21,803 USD	15/03/2024	19/03/2024
Kaufman Jonathan H O	0.79 USD	30,000 Bought	23,649 USD	15/03/2024	18/03/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Lipella Pharmaceuticals Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Last	52W Low	52W High	All-Time Low	All-Time High	β

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Kaufman Jonathan H	3	53,041.50	17,680.50	18/03/2024	14/05/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.